Lipocalin 2 has been shown to be useful for the early diagnosis, risk stratification and prognosis of sepsis in the emergency department [108,109], as well as for the detection of multiorgan dysfunction and mortality in patients with sepsis and septic shock [110,111]. This evidence concerns the gene LCN2 and Sepsis.